Sciaderm is developing a new and novel treatment for psoriasis with a mode of action that is different from othersents currently in use.
Contact Information
Contact Information
Employees: 11-50
Investors 1
| Date | Name | Website |
| - | Ben Frankl... | sep.benfra... |
Mentions in press and media 1
| Date | Title | Description |
| 17.05.2017 | Ben Franklin Approved 3.7M in 21 Early Stage Companies |